StablePharma
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.7Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2025-06-01attributed |
| Founded | unknown |
| Headquarters | London, UK |
| Industry | biotech |
| Stage | unknown |
| Website | stablepharma.com |
Stablepharma reformulates temperature-sensitive vaccines and drugs into thermostable versions that stay effective above 40C. It serves health systems and immunization programs in regions with weak cold chains. Its StablevaX platform removes refrigeration dependence, cutting vaccine waste.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-06-01 | grant | $2.7M | undisclosed |
Detected tech stack
LiteSpeed, WordPress 7.0, Bootstrap ecacb1bcdec99b6b61c17f5cedf36d09, Linkedin Sign-in, Yoast SEO 27.6, Google Analytics, Google Tag Manager, jQuery Migrate 3.4.1, Popper, DoubleClick Floodlight, Contact Form 7 6.1.6, WPMU DEV Smush 4.0.3
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | stablepharma.com, read 2026-05-08 |
| Description | self-reported | stablepharma.com, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.